Biomerica soars as Walmart begins selling colorectal disease test

Biomerica

01/10/2021 12:26

** Shares of diagnostic company  BMRA.O  soar nearly 39% to
$6.25 premarket - set to open at a more than 6-mth high
    ** Stock is top pct gainer across U.S. exchanges premarket,
with shares trading above their 50-, 150- and 200- day moving
average price
    ** BMRA says Walmart  WMT.N  has begun selling co's EZ
Detect colorectal disease screening test through its online
sales channel  urn:newsml:reuters.com:*:nGNXbkqXgs
    ** Co says it is in the final phase of working with WMT to
stock and sell the test on the shelf in the latter's stores
    ** Says it is also in negotiations with several large
partners for distribution of the test in Asia, Europe and the
Middle East
    ** The test is an at-home test to detect hidden blood in a
person's stool, which can be an early warning sign of colorectal
diseases, including colon and rectal cancers - co
    ** Colorectal cancer is the second most common cause of
cancer death in the United States, according to co
    ** BMRA down 9.6% YTD, up to the last close

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))